Results 301 to 310 of about 283,343 (354)

Methotrexate Update

Scandinavian Journal of Rheumatology, 1996
Methotrexate (MTX) has become one of the most widely prescribed second-line agents world-wide for rheumatoid arthritis (RA). Studies have established efficacy in populations which have failed other second-line agents. Although MTX must be considered as a potential hepatotoxin, studies have shown that liver histologic changes can be predicted by ...
openaire   +2 more sources

INTRATHECAL METHOTREXATE

The Lancet, 1970
G, Pasquinucci, R, Pardini, F, Fedi
  +7 more sources

Methotrexate

Clinics in Dermatology, 1997
S, Said, E W, Jeffes, G D, Weinstein
openaire   +2 more sources

Methotrexate

Journal of Pediatric Oncology Nursing, 1993
A S, O'Marcaigh, D L, Betcher
openaire   +2 more sources

Methotrexate osteopathy

Internal Medicine Journal, 2023
Matthew Youssef, Peter Youssef
openaire   +2 more sources

INTRATHECAL METHOTREXATE

The Lancet, 1972
E S, Baum, C P, Holton
openaire   +4 more sources

Methotrexate myelopathy

Brain and Development, 2019
Priyanka, Madaan, Lokesh, Saini
openaire   +2 more sources

METHOTREXATE MENINGITIS

The Lancet, 1972
M G, Mott, P, Stevenson, C B, Wood
openaire   +2 more sources

INTRATHECAL METHOTREXATE

The Lancet, 1971
F, Mollica, G, Schilirò, L, Pavone, F, Collica   +3 more
openaire   +4 more sources

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

Signal Transduction and Targeted Therapy, 2022
Xiaoying Zhang, Miao Miao, Xu Liu
exaly